Table 1. The content of lipid peroxidation products in the saliva of the studied groups.
Indicators |
Control Group |
Core Group |
p-value |
Lung Cancer |
|||
Diene Conjugates, c.u. |
4.23 [4.11; 4.33] |
4.30 [4.11; 4.37] |
0.2365 |
Triene Conjugates, c.u. |
0.650 [0.586; 0.760] |
0.755 [0.696; 0.778] |
0.0001* |
Shiff Bases, c.u. |
0.416 [0.389; 0.438] |
0.435 [0.407; 0.446] |
0.0413* |
MDA, nmol/ml |
8.42 [6.97; 11.54] |
8.12 [5.90; 11.88] |
0.7062 |
Breast cancer |
|||
Diene Conjugates, c.u. |
4.22 [4.13; 4.32] |
4.36 [4.20; 4.50] |
0.0021* |
Triene Conjugates, c.u. |
0.679 [0.588; 0.806] |
0.763 [0.693; 0.780] |
0.0385* |
Shiff Bases, c.u. |
0.411 [0.393; 0.427] |
0.468 [0.430; 0.494] |
0.0000* |
MDA, nmol/ml |
8.38 [6.03; 9.87] |
7.09 [5.98; 8.46] |
0.0723 |
Note. * - the differences are statistically significant, р˂0.05